Based on the Regencell Bioscience Holdings Ltd stock forecast from 0 analysts, the average analyst target price for Regencell Bioscience Holdings Ltd is not available over the next 12 months. Regencell Bioscience Holdings Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Regencell Bioscience Holdings Ltd is Slightly Bearish, which is based on 3 positive signals and 7 negative signals. At the last closing, Regencell Bioscience Holdings Ltd’s stock price was USD 5.55. Regencell Bioscience Holdings Ltd’s stock price has changed by +45.67% over the past week, +37.04% over the past month and -79.82% over the last year.
No recent analyst target price found for Regencell Bioscience Holdings Ltd
No recent average analyst rating found for Regencell Bioscience Holdings Ltd
Company Overview Regencell Bioscience Holdings Ltd
Regal Entertainment Group, together with its subsidiaries, operates as a motion picture exhibitor in the United States. The company develops, acquires, and operates multi-screen theatres primarily in mid-sized metropolitan markets and suburban growth areas of larger metropolitan markets. It operates a theatre circuit under the brands of Regal Cinemas, United Artists, Edwards, Great Escape Theatres, and Hollywood Theaters. As of March 7, 2017, the company operated 7,267 screens in 561 theatres in 42 states along with Guam, Saipan, American Samoa, and the District of Columbia. Regal Entertainment Group was founded in 2002 and is based in Knoxville, Tennessee. Read Less
Regal Entertainment Group, together with its subsidiaries, operates as a motion picture exhibitor in the United States. The company develops, acquires, and operates multi-screen theatres primarily in mid-sized metropolitan markets and suburban growth areas of larger metropolitan ...Read More
Frequently Asked Questions About Regencell Bioscience Holdings Ltd (RGC) Stock
Stock Target Advisor's fundamental analysis for Regencell Bioscience Holdings Ltd's stock is Slightly Bearish.
RGC stock's dividend yield is 382.80%.
Our analysis grades RGC stock's dividend yield at B+. This means that RGC stock's dividend yield is above 88% of the stocks in the Other sector in the NSD exchange.
Based on this RGC may be a good dividend stock for its sector.
Unfortunately we do not have enough data on RGC's stock to indicate what its average analyst target is.
RGC stock's Price/Earning ratio is 26.21.
Our analysis grades RGC stock's Price / Earning ratio at F. This means that RGC stock's Price/Earning ratio is above 68% of the stocks in the Other sector in the NSD exchange.
Based on this RGC may be a overvalued for its sector.
The last closing price of RGC's stock was USD 5.55.
The most recent market capitalization for RGC is USD 3.60B.
Unfortunately we do not have enough analyst data on RGC's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Regencell Bioscience Holdings Ltd's stock.
As per our most recent records Regencell Bioscience Holdings Ltd has 25,359 Employees.
Regencell Bioscience Holdings Ltd's registered address is 101 East Blount Avenue
37920,Knoxville,USA
.
You can get more information about it from Regencell Bioscience Holdings Ltd's website at http://www.regmovies.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative Book Value
The company has negative book value.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for RGC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
